Craig Hottenbach's questions to GoodRx Holdings Inc (GDRX) leadership • Q2 2025
Question
Jay, on behalf of Craig Hottenbach of Morgan Stanley, asked for details on the cost controls and margin levers being used to maintain EBITDA guidance despite a lower revenue outlook, and also inquired about any shifts in consumer behavior.
Answer
CFO Chris McGinnis explained that margins are being maintained through a combination of favorable mix shift (as lost ISP revenue was lower margin) and disciplined cost controls, including a workforce reduction and resource reallocation. CEO Wendy Barnes added this reflects a focus on core strategic initiatives. McGinnis noted a short-term consumer shift to funded benefits due to higher cash prices but expects tailwinds to reverse this trend in 2026.